Nicolas van Mieghem
Overview
Explore the profile of Nicolas van Mieghem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalique O, Zaid S, Tang G, Abdel-Wahab M, Akodad M, Bapat V, et al.
J Am Coll Cardiol
. 2025 Mar;
85(10):1042-1055.
PMID: 40074470
This updated Heart Valve Collaboratory framework addresses the growing concern for transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR). With the increasing volume of redo-TAV and surgical TAV...
2.
Tarantini G, Fraccaro C, Porzionato A, van Mieghem N, Treede H, Shammas N, et al.
Am J Cardiol
. 2025 Jan;
241:77-83.
PMID: 39870321
Advances in personalized medicine and Systems Biology have introduced probabilistic models and error discovery to cardiovascular care, aiding disease prevention and procedural planning. However, clinical application faces cultural, technical, and...
3.
Schafer A, Alasnag M, Giacoppo D, Collet C, Rudolph T, Roguin A, et al.
EuroIntervention
. 2025 Jan;
21(1):22-34.
PMID: 39773827
This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to...
4.
Zgheib A, De Backer O, Afilalo J, Quagliana A, Campens L, Asmar M, et al.
JACC Cardiovasc Interv
. 2024 Dec;
17(23):2713-2731.
PMID: 39663053
Despite the challenges associated with periprocedural imaging, transcatheter tricuspid valve interventions have shown important impact on outcomes. A comprehensive understanding of the anatomy of the right heart and surrounding structures...
5.
Guthoff H, Abdel-Wahab M, Kim W, Witberg G, Wienemann H, Thurow M, et al.
JACC Cardiovasc Interv
. 2024 Nov;
17(22):2626-2635.
PMID: 39603776
Background: Prosthesis-patient mismatch after transcatheter aortic valve replacement (TAVR) can be measured echocardiographically (measured prosthesis-patient mismatch [PPMm]) or predicted (predicted prosthesis-patient mismatch [PPMp]) using published effective orifice area (EOA) reference...
6.
Di Muro F, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio A, et al.
Am J Cardiol
. 2024 Nov;
236():56-63.
PMID: 39522578
Limited evidence exists concerning the prognostic impact of baseline left ventricular ejection fraction (LVEF) on outcomes among women undergoing transcatheter aortic valve implantation (TAVI), which we aimed to investigate in...
7.
Sharma S, Verhemel S, Hirsch A, van der Bie J, Dijkshoorn M, Daemen J, et al.
Int J Cardiovasc Imaging
. 2024 Nov;
PMID: 39495429
We assessed the diagnostic performance of both ultra-high-resolution (UHR) and high-resolution (HR) modes of photon-counting detector (PCD)-CT within the confines of standard pre-TAVI CT scans, as well as the performance...
8.
Nuis R, van den Dorpel M, Adrichem R, Daemen J, van Mieghem N
Interv Cardiol
. 2024 Sep;
19:e12.
PMID: 39221063
The demonstrated safety and effectiveness of transcatheter aortic valve implantation (TAVI) among low surgical risk patients opened the road to its application in younger low-risk patients. However, the occurrence of...
9.
Teles R, Van Belle E, Parma R, Tarantini G, van Mieghem N, Mylotte D, et al.
EuroIntervention
. 2024 Aug;
PMID: 39207816
The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define...
10.
Faza N, Harb S, Wang D, van den Dorpel M, van Mieghem N, Little S
JACC Cardiovasc Imaging
. 2024 Apr;
17(4):428-440.
PMID: 38569793
Structural heart disease interventions rely heavily on preprocedural planning and simulation to improve procedural outcomes and predict and prevent potential procedural complications. Modeling technologies, namely 3-dimensional (3D) printing and computational...